Suppr超能文献

溶瘤腺病毒与肝细胞相互作用的体内追踪

In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells.

作者信息

Naumenko Victor A, Vishnevskiy Daniil A, Stepanenko Aleksei A, Sosnovtseva Anastasiia O, Chernysheva Anastasiia A, Abakumova Tatiana O, Valikhov Marat P, Lipatova Anastasiia V, Abakumov Maxim A, Chekhonin Vladimir P

机构信息

V. Serbsky National Medical Research Center for Psychiatry and Narcology, 119034 Moscow, Russia.

Department of Medical Nanobiotechnology, N.I Pirogov Russian National Research Medical University, 117997 Moscow, Russia.

出版信息

Biomedicines. 2022 Jul 13;10(7):1697. doi: 10.3390/biomedicines10071697.

Abstract

Hepatotoxicity remains an as yet unsolved problem for adenovirus (Ad) cancer therapy. The toxic effects originate both from rapid Kupffer cell (KCs) death (early phase) and hepatocyte transduction (late phase). Several host factors and capsid components are known to contribute to hepatotoxicity, however, the complex interplay between Ad and liver cells is not fully understood. Here, by using intravital microscopy, we aimed to follow the infection and immune response in mouse liver from the first minutes up to 72 h post intravenous injection of three Ads carrying delta-24 modification (Ad5-RGD, Ad5/3, and Ad5/35). At 15-30 min following the infusion of Ad5-RGD and Ad5/3 (but not Ad5/35), the virus-bound macrophages demonstrated signs of zeiosis: the formation of long-extended protrusions and dynamic membrane blebbing with the virus release into the blood in the membrane-associated vesicles. Although real-time imaging revealed interactions between the neutrophils and virus-bound KCs within minutes after treatment, and long-term contacts of CD8+ T cells with transduced hepatocytes at 24-72 h, depletion of neutrophils and CD8+ T cells affected neither rate nor dynamics of liver infection. Ad5-RGD failed to complete replicative cycle in hepatocytes, and transduced cells remained impermeable for propidium iodide, with a small fraction undergoing spontaneous apoptosis. In Ad5-RGD-immune mice, the virus neither killed KCs nor transduced hepatocytes, while in the setting of hepatic regeneration, Ad5-RGD enhanced liver transduction. The clinical and biochemical signs of hepatotoxicity correlated well with KC death, but not hepatocyte transduction. Real-time in vivo tracking for dynamic interactions between virus and host cells provides a better understanding of mechanisms underlying Ad-related hepatotoxicity.

摘要

肝毒性仍然是腺病毒(Ad)癌症治疗中一个尚未解决的问题。毒性作用既源于库普弗细胞(KCs)的快速死亡(早期阶段),也源于肝细胞转导(晚期阶段)。已知几种宿主因素和衣壳成分会导致肝毒性,然而,Ad与肝细胞之间复杂的相互作用尚未完全了解。在这里,我们通过活体显微镜检查,旨在追踪静脉注射三种携带delta-24修饰的Ad(Ad5-RGD、Ad5/3和Ad5/35)后,小鼠肝脏从最初几分钟到72小时的感染和免疫反应。在输注Ad5-RGD和Ad5/3(但不是Ad5/35)后的15 - 30分钟,与病毒结合的巨噬细胞出现了细胞溶解的迹象:形成长而延伸的突起以及动态的膜泡形成,病毒通过膜相关囊泡释放到血液中。尽管实时成像显示治疗后几分钟内中性粒细胞与病毒结合的KCs之间存在相互作用,以及24 - 72小时时CD8 + T细胞与转导的肝细胞之间存在长期接触,但中性粒细胞和CD8 + T细胞的耗竭既不影响肝脏感染的速率也不影响其动态过程。Ad5-RGD未能在肝细胞中完成复制周期,转导的细胞对碘化丙啶仍不可渗透,只有一小部分细胞发生自发凋亡。在Ad5-RGD免疫的小鼠中,病毒既不杀死KCs也不转导肝细胞,而在肝再生的情况下,Ad5-RGD增强了肝脏转导。肝毒性的临床和生化体征与KCs死亡密切相关,但与肝细胞转导无关。对病毒与宿主细胞之间动态相互作用的实时体内追踪有助于更好地理解Ad相关肝毒性的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0880/9313019/4fe50d8df65f/biomedicines-10-01697-g001.jpg

相似文献

1
In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells.
Biomedicines. 2022 Jul 13;10(7):1697. doi: 10.3390/biomedicines10071697.
3
Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver.
Mol Ther. 2009 Apr;17(4):675-84. doi: 10.1038/mt.2008.307. Epub 2009 Feb 17.
4
Circulating antibodies and macrophages as modulators of adenovirus pharmacology.
J Virol. 2013 Apr;87(7):3678-86. doi: 10.1128/JVI.01392-12. Epub 2013 Jan 16.
5
Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver.
Hum Gene Ther. 2008 May;19(5):547-54. doi: 10.1089/hum.2008.004.
6
Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX.
Virus Res. 2018 Sep 15;257:40-51. doi: 10.1016/j.virusres.2018.08.012. Epub 2018 Aug 17.

引用本文的文献

1
Synergy of oncolytic adenovirus and immune checkpoint inhibitors: transforming cancer immunotherapy paradigms.
Front Immunol. 2025 Jul 8;16:1610858. doi: 10.3389/fimmu.2025.1610858. eCollection 2025.
3
Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation.
Mol Ther. 2025 May 7;33(5):2217-2228. doi: 10.1016/j.ymthe.2025.03.035. Epub 2025 Mar 25.
4
Improving systemic delivery of oncolytic virus by cellular carriers.
Cancer Biol Med. 2025 Jan 17;21(12):1104-19. doi: 10.20892/j.issn.2095-3941.2024.0390.
6
The Immune System-A Double-Edged Sword for Adenovirus-Based Therapies.
Viruses. 2024 Jun 17;16(6):973. doi: 10.3390/v16060973.
7
Emerging delivery strategy for oncolytic virotherapy.
Mol Ther Oncol. 2024 Apr 29;32(2):200809. doi: 10.1016/j.omton.2024.200809. eCollection 2024 Jun 20.
9
Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time.
Front Immunol. 2023 May 16;14:1176594. doi: 10.3389/fimmu.2023.1176594. eCollection 2023.

本文引用的文献

1
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?
Mol Ther Oncolytics. 2022 Feb 12;24:663-682. doi: 10.1016/j.omto.2022.02.004. eCollection 2022 Mar 17.
2
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures.
Mol Ther Oncolytics. 2021 Dec 21;24:230-248. doi: 10.1016/j.omto.2021.12.013. eCollection 2022 Mar 17.
3
Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy.
Cytotherapy. 2021 Dec;23(12):1045-1052. doi: 10.1016/j.jcyt.2021.07.013. Epub 2021 Sep 20.
5
Comprehensive analysis of liver macrophage composition by flow cytometry and immunofluorescence in murine NASH.
STAR Protoc. 2021 Apr 29;2(2):100511. doi: 10.1016/j.xpro.2021.100511. eCollection 2021 Jun 18.
6
Systemic cancer therapy with engineered adenovirus that evades innate immunity.
Sci Transl Med. 2020 Nov 25;12(571). doi: 10.1126/scitranslmed.abc6659.
7
Live Imaging of Innate and Adaptive Immune Responses in the Liver.
Front Immunol. 2020 Sep 17;11:564768. doi: 10.3389/fimmu.2020.564768. eCollection 2020.
8
Interaction of adenovirus with antibodies, complement, and coagulation factors.
FEBS Lett. 2019 Dec;593(24):3449-3460. doi: 10.1002/1873-3468.13649. Epub 2019 Nov 15.
9
Dynamics and genomic landscape of CD8 T cells undergoing hepatic priming.
Nature. 2019 Oct;574(7777):200-205. doi: 10.1038/s41586-019-1620-6. Epub 2019 Oct 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验